Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore professional investment ideas sourced from institutional letters, short theses, and premium research channels, distilled into concise summaries.
| Pitch Type | Author | Industry | Pitch Thesis & Key Summary | Bull/Bear | Action | ||
|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | Fund Letter | John Brown, Drew JustmanMadison Dividend Income Fund | Life Sciences Tools & ServicesLife Sciences Tools & Services | Long CRL (Charles River) Our investments in drug development companies like Charles River Labs (CRL) and Medpace Holdings (MEDP) pulled back, driven by AI disruption fears. | BULL | View Pitch → | |
| Feb 3, 2026 | Fund Letter | Jonathan Edwards, Jonathan MuellerInvesco Small Cap Value Fund | Life Sciences Tools & ServicesLife Sciences Tools & Services | Invesco Small Cap Value Fund 2025 Q4 (CRL) Charles River Laboratories was added as a new position. This leading CRO... | BULL | View Pitch → | |
| Jan 20, 2026 | Fund Letter | John W. RogersAriel Appreciation Fund | Life Sciences Tools & ServicesLife Sciences Tools & Services | Ariel Appreciation Fund 2025 Q4 (CRL) Charles River Laboratories (CRL) also traded higher on solid quarterly results, reinforcing its position as a leader in outsourced drug development services. While biotech funding... | BULL | View Pitch → | |
| Nov 28, 2025 | Fund Letter | Faraz Farzam, Aaron GarciaMadison Small Cap Fund | Life Sciences Tools & ServicesLife Sciences Tools & Services | Madison Small Cap Fund 2025 Q3 (CRL) We initiated a position in Charles River Labs in Q3. CRL is a... | BULL | View Pitch → |
Join institutional and professional investors receiving our weekly analysis of hedge fund letters, market trends, and high-conviction ideas.
Zero Spam • High Alpha • Unsubscribe Anytime
Investment pitches and theses displayed on Buyside Digest are summaries of opinions expressed in publicly available investor letters, research reports, or other commentary. These summaries are generated for informational and research purposes only and do not constitute investment recommendations, financial advice, or an endorsement of any particular security or strategy by Buyside Digest. Users should conduct their own independent due diligence and consult with professional advisors before making any investment decisions.